PURPOSE: By their control of membrane potential and intracellular free Ca(2+) ([Ca(2+)](i)), K(+) currents are pivotal in the regulation of arterial smooth muscle tone. The goal of the present study was to identify and characterize the A-type K(+) current in retinal microvascular smooth muscle (MVSM) and to examine its role in modulating membrane potential and cellular contractility. METHODS: Whole-cell perforated patch-clamp recordings were made from MVSM cells within intact isolated arteriolar segments. Before patch-clamping, retinal arterioles were anchored in the physiological recording bath and perfused with an enzyme cocktail to remove surface basal lamina and to uncouple electrically the endothelial cells from the overlying MVSM cells. RESULTS: K(+) currents were activated by depolarizing steps from -80 to +100 mV in 20-mV increments. A dominant, noninactivating current was elicited by depolarization to potentials positive of -50 mV. Inhibition of this current by 100 nM of the Ca(2+)-activated K(+) channel blocker, Penitrem A, revealed a rapidly inactivating K(+) current that resembled an A-type current. The A-type current was insensitive to tetraethylammonium (TEA) at 1 mM, but was partially suppressed by higher concentrations (10 mM). 4-Aminopyridine (10 mM; 4-AP) completely blocked the A-type current. The 4-AP-sensitive transient current was activated at a potential of -60 mV with peak current densities averaging 29.7 +/- 5.68 pA/pF at +60 mV. The voltage of half-inactivation was -28.3 +/- 1.9 mV, and the time constant for recovery from inactivation at +60 mV was 118.7 +/- 7.9 ms. Under current-clamp conditions 4-AP depolarized the membrane potential by approximately 3 to 4 mV and triggered small contractions and relaxations of individual MVSM cells within the walls of the arterioles. CONCLUSIONS: A-type current is the major voltage-dependent K(+) current in retinal MVSM and appears to play a physiological role in suppressing cell excitability and contractility.
PURPOSE: By their control of membrane potential and intracellular free Ca(2+) ([Ca(2+)](i)), K(+) currents are pivotal in the regulation of arterial smooth muscle tone. The goal of the present study was to identify and characterize the A-type K(+) current in retinal microvascular smooth muscle (MVSM) and to examine its role in modulating membrane potential and cellular contractility. METHODS: Whole-cell perforated patch-clamp recordings were made from MVSM cells within intact isolated arteriolar segments. Before patch-clamping, retinal arterioles were anchored in the physiological recording bath and perfused with an enzyme cocktail to remove surface basal lamina and to uncouple electrically the endothelial cells from the overlying MVSM cells. RESULTS: K(+) currents were activated by depolarizing steps from -80 to +100 mV in 20-mV increments. A dominant, noninactivating current was elicited by depolarization to potentials positive of -50 mV. Inhibition of this current by 100 nM of the Ca(2+)-activated K(+) channel blocker, Penitrem A, revealed a rapidly inactivating K(+) current that resembled an A-type current. The A-type current was insensitive to tetraethylammonium (TEA) at 1 mM, but was partially suppressed by higher concentrations (10 mM). 4-Aminopyridine (10 mM; 4-AP) completely blocked the A-type current. The 4-AP-sensitive transient current was activated at a potential of -60 mV with peak current densities averaging 29.7 +/- 5.68 pA/pF at +60 mV. The voltage of half-inactivation was -28.3 +/- 1.9 mV, and the time constant for recovery from inactivation at +60 mV was 118.7 +/- 7.9 ms. Under current-clamp conditions 4-AP depolarized the membrane potential by approximately 3 to 4 mV and triggered small contractions and relaxations of individual MVSM cells within the walls of the arterioles. CONCLUSIONS: A-type current is the major voltage-dependent K(+) current in retinal MVSM and appears to play a physiological role in suppressing cell excitability and contractility.
Authors: Gregory C Amberg; Salah A Baker; Sang Don Koh; William J Hatton; Keith J Murray; Burton Horowitz; Kenton M Sanders Journal: J Physiol Date: 2002-10-15 Impact factor: 5.182
Authors: Mary K McGahon; Jennine M Dawicki; Aruna Arora; D A Simpson; T A Gardiner; A W Stitt; C Norman Scholfield; J Graham McGeown; Tim M Curtis Journal: Am J Physiol Heart Circ Physiol Date: 2006-10-13 Impact factor: 4.733
Authors: Maurice Needham; Mary K McGahon; Peter Bankhead; Tom A Gardiner; C Norman Scholfield; Tim M Curtis; J Graham McGeown Journal: Invest Ophthalmol Vis Sci Date: 2014-04-07 Impact factor: 4.799
Authors: Mary K McGahon; Durga P Dash; Aruna Arora; Noreen Wall; Jennine Dawicki; David A Simpson; C Norman Scholfield; J Graham McGeown; Tim M Curtis Journal: Circ Res Date: 2007-02-09 Impact factor: 17.367
Authors: Mary K McGahon; Xiaohong Zhang; C Norman Scholfield; Timothy M Curtis; J Graham McGeown Journal: Channels (Austin) Date: 2007-06-18 Impact factor: 2.581
Authors: Mary K McGahon; Maurice A Needham; C Norman Scholfield; J Graham McGeown; Tim M Curtis Journal: Invest Ophthalmol Vis Sci Date: 2008-09-04 Impact factor: 4.799
Authors: Vahagn Ohanyan; Sean M Raph; Marc M Dwenger; Xuemei Hu; Thomas Pucci; Gregory Mack; Joseph B Moore; William M Chilian; Aruni Bhatnagar; Matthew A Nystoriak Journal: Circ Res Date: 2021-01-27 Impact factor: 17.367